AN2 Therapeutics director Margaret M. FitzPatrick acquires 2,098 common shares worth $11,602.94
ANTX•Director share purchase
- AN2 Therapeutics director Margaret M. FitzPatrick bought 2,098 common shares at $5.53 each, a Form 4 filing shows.
- Her direct holding rose to 10,708 shares following the purchase.
